EyePoint Pharmaceuticals
EYPT
EYPT
57 hedge funds and large institutions have $111M invested in EyePoint Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
2% less funds holding
Funds holding: 58 → 57 (-1)
Holders
57
Holding in Top 10
1
Calls
$297K
Puts
$191K
Top Buyers
| 1 | +$930K | |
| 2 | +$587K | |
| 3 | +$344K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$224K |
| 5 |
BlackRock
New York
|
+$182K |
Top Sellers
| 1 | -$748K | |
| 2 | -$577K | |
| 3 | -$525K | |
| 4 |
Jane Street
New York
|
-$332K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$244K |